CG Oncology, Inc.
CGON
$42.61
$1.243.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -151.48M | -128.08M | -105.56M | -88.04M | -72.80M |
| Total Depreciation and Amortization | 596.00K | 201.00K | 52.00K | 32.00K | 36.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -9.00K |
| Total Other Non-Cash Items | 22.94M | 16.63M | 11.76M | 6.39M | -522.00K |
| Change in Net Operating Assets | 11.16M | 17.43M | 11.77M | 2.91M | 595.00K |
| Cash from Operations | -116.79M | -93.82M | -81.98M | -78.71M | -72.70M |
| Capital Expenditure | -336.00K | -238.00K | -238.00K | -234.00K | -25.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -21.97M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -137.11M | -142.21M | -179.85M | -300.53M | -296.11M |
| Cash from Investing | -159.41M | -142.45M | -180.09M | -300.76M | -296.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -365.00K | -372.00K |
| Issuance of Common Stock | 278.22M | 226.28M | 226.34M | 632.07M | 408.92M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 410.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -277.00K | -547.00K | -269.00K | -3.42M | -6.99M |
| Cash from Financing | 277.94M | 225.74M | 226.07M | 628.28M | 401.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.73M | -10.53M | -36.00M | 248.80M | 33.14M |